ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions

The ISSCR’s revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization’s commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards....

Descripción completa

Detalles Bibliográficos
Autor principal: Turner, Leigh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190662/
https://www.ncbi.nlm.nih.gov/pubmed/34048693
http://dx.doi.org/10.1016/j.stemcr.2021.05.011
_version_ 1783705731337289728
author Turner, Leigh
author_facet Turner, Leigh
author_sort Turner, Leigh
collection PubMed
description The ISSCR’s revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization’s commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.
format Online
Article
Text
id pubmed-8190662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81906622021-06-17 ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions Turner, Leigh Stem Cell Reports Commentary The ISSCR’s revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization’s commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products. Elsevier 2021-05-27 /pmc/articles/PMC8190662/ /pubmed/34048693 http://dx.doi.org/10.1016/j.stemcr.2021.05.011 Text en © 2021 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Turner, Leigh
ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions
title ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions
title_full ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions
title_fullStr ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions
title_full_unstemmed ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions
title_short ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions
title_sort isscr’s guidelines for stem cell research and clinical translation: supporting development of safe and efficacious stem cell-based interventions
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190662/
https://www.ncbi.nlm.nih.gov/pubmed/34048693
http://dx.doi.org/10.1016/j.stemcr.2021.05.011
work_keys_str_mv AT turnerleigh isscrsguidelinesforstemcellresearchandclinicaltranslationsupportingdevelopmentofsafeandefficaciousstemcellbasedinterventions

Ejemplares similares